000 01547 a2200457 4500
005 20250513092919.0
264 0 _c19960905
008 199609s 0 0 eng d
022 _a0340-6997
024 7 _a10.1007/BF00833392
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKraeber-Bodéré, F
245 0 0 _aPharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.
_h[electronic resource]
260 _bEuropean journal of nuclear medicine
_cMay 1996
300 _a560-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCystadenocarcinoma, Serous
_xradiotherapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsothiocyanates
_xpharmacokinetics
650 0 4 _aIsotope Labeling
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Transplantation
650 0 4 _aOvarian Neoplasms
_xradiotherapy
650 0 4 _aPentetic Acid
_xanalogs & derivatives
650 0 4 _aRadioimmunotherapy
650 0 4 _aRadioisotopes
_xpharmacokinetics
650 0 4 _aSamarium
_xpharmacokinetics
650 0 4 _aTissue Distribution
700 1 _aMishra, A
700 1 _aThédrez, P
700 1 _aFaivre-Chauvet, A
700 1 _aBardiès, M
700 1 _aImai, S
700 1 _aLe Boterff, J
700 1 _aChatal, J F
773 0 _tEuropean journal of nuclear medicine
_gvol. 23
_gno. 5
_gp. 560-7
856 4 0 _uhttps://doi.org/10.1007/BF00833392
_zAvailable from publisher's website
999 _c8695350
_d8695350